20 studies found for: Open Studies | "Respiratory Syncytial Virus Infections"
The Development of a Human Model of Respiratory Syncytial Virus Infection
|2||Not yet recruiting||
Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immuno Compromised Children With Synagis
A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Respiratory Syncytial Virus - RSV Protocol
Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
A Study of ALS-008176 in Infants Hospitalized With RSV
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Safety, Tolerability and PK Study of AK0529 in Healthy Human
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
RSV Observational Study 2
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
TGF-(Beta) and Susceptibility to RSV
RSV Disease in the Elderly
† Indicates status has not been verified in more than two years